Articles published through PrecISE research

Last updated April 1, 2025

 

  1. Ivanova, A., Israel, E., LaVange, L. M., Peters, M. C., Denlinger, L. C., Moore, W. C., Bacharier, L. B., Marquis, M. A., Gotman, N. M., Kosorok, M. R., Tomlinson, C., Mauger, D. T., Georas, S. N., Wright, R. J., Noel, P., Rosner, G. L., Akuthota, P., Billheimer, D., Bleecker, E. R., Cardet, J. C., … White, S. R. (2020). The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. Journal of biopharmaceutical statistics, 30(6), 1026–1037. https://doi.org/10.1080/10543406.2020.1821705. PubMed ID: 32941098.

     

  2. Israel, E., Denlinger, L. C., Bacharier, L. B., LaVange, L. M., Moore, W. C., Peters, M. C., Georas, S. N., Wright, R. J., Mauger, D. T., Noel, P., Akuthota, P., Bach, J., Bleecker, E. R., Cardet, J. C., Carr, T. F., Castro, M., Cinelli, A., Comhair, S. A. A., Covar, R. A., Alexander, L. C., … Ivanova, A. (2021). PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment. The Journal of allergy and clinical immunology, 147(5), 1594–1601. https://doi.org/10.1016/j.jaci.2021.01.037, PubMed ID: 33667479.

     

  3. Georas, S. N., Wright, R. J., Ivanova, A., Israel, E., LaVange, L. M., Akuthota, P., Carr, T. F., Denlinger, L. C., Fajt, M. L., Kumar, R., O'Neal, W. K., Phipatanakul, W., Szefler, S. J., Aronica, M. A., Bacharier, L. B., Burbank, A. J., Castro, M., Crotty Alexander, L., Bamdad, J., Cardet, J. C., … PrecISE Study Team (2022). The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. The Journal of allergy and clinical immunology, 149(2), 488–516.e9. https://doi.org/10.1016/j.jaci.2021.10.035. PubMed ID: 34848210.

     

  4. Carr, T. F., Fajt, M. L., Kraft, M., Phipatanakul, W., Szefler, S. J., Zeki, A. A., Peden, D. B., White, S. R., & Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Research Group (2023). Treating asthma in the time of COVID. The Journal of allergy and clinical immunology, 151(4), 809–817. https://doi.org/10.1016/j.jaci.2022.12.800. PubMed ID: 36528110.

     

  5. Song, T., LaVange, L. M., & Ivanova, A. (2024). Covariate-adaptive biased coin randomization for master protocols with multiple interventions and biomarker-stratified allocation. Statistics in biopharmaceutical research, 16(4), 526–531. https://doi.org/10.1080/19466315.2023.2268313. PubMed ID: 39743987.

     

  6. Zhao, B., Ivanova, A., & Fine, J. (2023). Inference on subgroups identified based on a heterogeneous treatment effect in a post hoc analysis of a clinical trial. Clinical trials (London, England), 20(4), 370–379. https://doi.org/10.1177/17407745231173055. PubMed ID: 37170632.

     

  7. Chang, Y., Song, T., Monaco, J., & Ivanova, A. (2020). Futility stopping in clinical trials, optimality and practical considerations. Journal of biopharmaceutical statistics, 30(6), 1050–1059. https://doi.org/10.1080/10543406.2020.1818253. PubMed ID: 32926648.

     

  8. Joshi, N., Nguyen, C., & Ivanova, A. (2020). Multi-stage adaptive enrichment trial design with subgroup estimation. Journal of biopharmaceutical statistics, 30(6), 1038–1049. https://doi.org/10.1080/10543406.2020.1832109. PubMed ID: 33073685.

     

  9. Zhao, B., Fine, J., & Ivanova, A. (2024). Finding the best subgroup with differential treatment effect with multiple outcomes. Statistics in medicine, 43(13), 2487–2500. https://doi.org/10.1002/sim.10083. PubMed ID: 38621856.

     

  10. Li, L., & Ivanova, A. (2024). Isotonic design for single-arm biomarker stratified trials. Statistical methods in medical research, 33(6), 945–952. https://doi.org/10.1177/09622802241238978. PubMed ID: 38573793.

     

  11. Li, L., & Ivanova, A. (2024). Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial. Biometrics, 80(2), ujae056. https://doi.org/10.1093/biomtc/ujae056. PubMed ID: 38861372.